APPLICATION OF POLYVALENT BACTERIAL LYSATES - ISMIZHENA IN THE TREATMENT OF CHRONIC PHARYNGITIS AND FARINGOTRAHEOBRONHITIS
Abstract
The article presents the results of of 97 patients with chronic pharyngitis and chronic pharyngotracheobronchitis in the acute stage. Clinical studies have led to the conclusion that the use ofthe drug Ismijencauses stimulation and increasing of severity of cell-mediated and humoral immunity.
Keywords:
Polyvalent bacterial lysates, pharyngitis, pharyngotracheobronchitis, Ismijen.References
1. Maul J. Stimullation of imunoprotective mechanisms by OM–85 BV. Respiration,1994, N 61 (Suppl. 1), P.8–15.
2. Braido F, Villa E, Schenone G, Canonica GW and Melioli G, A good clinical outcome therapy with a polyvalent mechanical bacterial lysate (PMBL) correlates with the capacity of inducing a speciэc locoregional immunoresponse in patients with recurrent upper respiratory tract infection, XXVII Congress of the European Academy of Allergology and Clinical Immunology, 2008.
3. Fuggetta MP and LanzilliG, Attivazion edelleris poste immunitarie mediantev accinibatterici, EurRespir News 15: pp69-77, 2007.
4. La Mantia I, Nicolosi F, Maiolino L and Serra A, Immunoprophylaxis of recurring bacterial infections of respiratory tracts in pediatric age: clinical experience through a new immuneоstimulating vaccine (It),GIMMOC, Quaderni di Microbiologia e Clinica XI: pp1-8, 2007.
5. Aksic OT, Cattaneo L and Rosaschino F, Evaluation of the clinical efэcacy of a new polyvalent bacterial lysate obtained by mechanical lysis (PMBL) in a population of 180 school-aged children with recurrent respiratory infections, European Journal of Aerobiology Environmental Medicine and Air-borne Infections 1: p1, 2005.
6. Villa E, Garelli V, Braido F, MelioliGandCanonica GW,; May we strengthen the human natural defenses with bacterial lysates. World Allergy Organization Journal 3(8): ppS17-S23, 2010.
7. Tricarico D, Varricchio A, D’Ambrosio S, Ascione E and Motta G, Prevention of recurrent upper respiratory tract infections in a community of cloistered nuns using a new immunostimulating bacterial lysate: a randomized, double-blind clinical trial, Arzneimittelforschung 54: pp57-63, 2004.
8. Cazzola M, A new bacterial lysate protects by reducing infectious exacerbations in moderate to very severe COPD: a double-blind, randomized, placebo controlled trial, Trends in Med 6: pp191-199, 2006;
9. Cazzola M, Noschese P and Di Perna F, Value of adding a polyvalent mechanical bacterial lysate to therapy of COPD patients under regular treatment with salmeterol / (uti-casone, Therapeutics Advances in Respiratory Diseases 3(2): pp59-63, 2009.
